Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zorn

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|May 7, 1994
Nerves from pelvic plexus contribute to chronic orchidalgiaB H Zorn, L R Watson, W D Steers
Urology|February 1, 1991
Cost-benefit analysis of pharmacologic erection program (PEP) versus penile prosthesisJ P Buch, B H Zorn, R J Taylor
Applied Microbiology and Biotechnology|April 30, 2003
Cleavage of beta,beta-carotene to flavor compounds by fungiH Zorn, S Langhoff, M Scheibner, et al.
Biological Chemistry|June 6, 2000
Purification, characterisation and cDNA sequencing of pyruvate decarboxylase from Zygosaccharomyces bisporusF Neuser, H Zorn, U Richter, et al.
Pharmacology & Therapeutics|November 10, 2015
Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessmentJoanna M Wierońska, Stevin H Zorn, Dario Doller, et al.
European Journal of Pharmacology|February 10, 1998
Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activationH Rollema, Y Lu, A W Schmidt, et al.
Current Opinion in Chemical Biology|September 16, 1998
The discovery of potent and selective dopamine D4 receptor antagonistsW S Faraci, S H Zorn, M A Sanner, et al.
Neurochemical Research|March 1, 1989
Effects of reserpine on dopamine metabolite in the nucleus accumbens and locomotor activity in freely moving ratsR Sugita, Y Sawa, S Nomura, et al.
The Journal of Urology|June 24, 1999
Urinary incontinence and depressionB H Zorn, H Montgomery, K Pieper, et al.
Psychopharmacology|March 13, 1998
Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibitionR S Mansbach, E W Brooks, M A Sanner, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|May 7, 1994
Nerves from pelvic plexus contribute to chronic orchidalgiaB H Zorn, L R Watson, W D Steers
Urology|February 1, 1991
Cost-benefit analysis of pharmacologic erection program (PEP) versus penile prosthesisJ P Buch, B H Zorn, R J Taylor
Applied Microbiology and Biotechnology|April 30, 2003
Cleavage of beta,beta-carotene to flavor compounds by fungiH Zorn, S Langhoff, M Scheibner, et al.
Biological Chemistry|June 6, 2000
Purification, characterisation and cDNA sequencing of pyruvate decarboxylase from Zygosaccharomyces bisporusF Neuser, H Zorn, U Richter, et al.
Pharmacology & Therapeutics|November 10, 2015
Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessmentJoanna M Wierońska, Stevin H Zorn, Dario Doller, et al.
European Journal of Pharmacology|February 10, 1998
Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activationH Rollema, Y Lu, A W Schmidt, et al.
Current Opinion in Chemical Biology|September 16, 1998
The discovery of potent and selective dopamine D4 receptor antagonistsW S Faraci, S H Zorn, M A Sanner, et al.
Neurochemical Research|March 1, 1989
Effects of reserpine on dopamine metabolite in the nucleus accumbens and locomotor activity in freely moving ratsR Sugita, Y Sawa, S Nomura, et al.
The Journal of Urology|June 24, 1999
Urinary incontinence and depressionB H Zorn, H Montgomery, K Pieper, et al.
Psychopharmacology|March 13, 1998
Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibitionR S Mansbach, E W Brooks, M A Sanner, et al.
Pageof 9